Profiles of DARPP-32 in the insular cortex with schizophrenia: A postmortem brain study

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 8, 2011, Pages 1901-1907

  Nishiura, Keisuke ^a   Kunii, Yasuto ^a   Wada, Akira ^a   Matsumoto, Junya ^a   Yang, Qiaohui ^a   Ikemoto, Keiko ^a   Niwa, Shin Ichi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

DARPP 32; Immunohistochemistry; Postmortem brains; Rostral agranular insular cortex (RAIC); Schizophrenia

Indexed keywords

PHOSPHOPROTEIN DARPP 32;

ADULT; AGED; ARTICLE; AUTOPSY; BRAIN CELL; BRAIN REGION; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; GABAERGIC SYSTEM; GLUTAMATERGIC SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INSULA; MALE; NEUROPATHOLOGY; PAIN THRESHOLD; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SCHIZOPHRENIA;

ADULT; AGED; AGED, 80 AND OVER; CEREBRAL CORTEX; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURONS; PAIN THRESHOLD; SCHIZOPHRENIA;

EID: 82455199187     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.07.010     Document Type: Article

References (39)

1. Albert K.A., Hemmings H.C., Adamo A.I., Potkin S.G., Akbarian S., Sandman C.A., et al. Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. Arch Gen Psychiatry 2002, 59(8):705-712.
2. Apkarian A.V., Bushunell M.C., Treede R.D., Zubieta J.K. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 2005, 9(4):463-484.
3. Baliki M., Katz J., Chialvo D.R., Apkarian A.V. Single subject pharmacological-MRI (phMRI) study: modulation of brain activity of psoriatic arthritis pain by cyclooxygenase-2 inhibitor. Mol Pain 2005, 1:32-40.
4. Baracskay K.L., Haroutunian V., Meador-Woodruff J.H. Dopamine receptor signaling molecules are altered in elderly schizophrenic cortex. Synapse 2006, 60(4):271-279.
5. Becker A., Grecksch G., Zernig G., Ladstaetter E., Hiemke C., Schmitt U. Haloperidol and risperidone have specific effects on altered pain sensitivity in the ketamine model of schizophrenia. Psychopharmacolog (Berl) 2009, 202(4):579-587.
6. Clinton S.M., Ibrahim H.M., Frey K.A., Davis K.L., Haroutunian V., Meador-Woodruff J.H. Dopaminergic abnormalities in select thalamic nuclei in schizophrenia: involvement of the intracellular signal integrating proteins calcyon and spinophilin. Am J Psychiatry 2005, 162(10):1859-1871.
7. Colantuoni C., Hyde T.M., Mitkus S., Joseph A., Sartorius L., Aguirre C., et al. Age-related changes in the expression of schizophrenia susceptibility genes in the human prefrontal cortex. Brain Struct Funct 2008, 213(1-2):255-271.
8. Crespo-Facorro B., Kim J., Andreasen N.C., O'Leary D.S., Bockholt H.J., Magnotta V. Insular cortex abnormalities in schizophrenia: a structural magnetic resonance imaging study of first-episode patients. Schizophr Res 2000, 46(1):35-43.
9. Eastwood S.L., Burnet P.W., Harrison P.J. Decreased hippocampal expression of the susceptibility gene PPP3CC and other calcineurin subunits in schizophrenia. Biol Psychiatry 2005, 57(7):702-710.
10. Fudge J.L., Breitbart M.A., Danish M., Pannoni V. Insular and gustatory inputs to the caudal ventral striatum in primates. J Comp Neurol 2005, 490(2):101-118.
11. Gerber D.J., Hall D., Miyakawa T., Demars S., Gogos J.A., Karayiorgou M., et al. Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding calcineurin gamma subunit. PNAS 2003, 100(15):8993-8998.
12. Glahn D.C., Laird A.R., Ellison-Wright I., Thelen S.M., Robinson J.L., Lancaster J.L., et al. Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol Psychiatry 2008, 64(9):774-781.
13. Grebb J.A., Girault J.A., Ehrlich M., Greengard P. Chronic treatment of rats with SCH-23390 or raclopride does not affect the concentrations of DARPP-32 or its mRNA in dopamine-innervated brain regions. J Neurochem 1990, 55(1):204-207.
14. Greengard P. The neurobiology of slow synaptic transmission. Science 2001, 294(5544):1024-1030.
15. Halpain S., Girault J.A., Greengard P. Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices. Nature 1990, 343(6256):369-372.
16. Hashimoto T., Matsubara T., Lewis D.A. Schizophrenia and cortical GABA neurotransmission. Psychiatry Neurol Jpn (Seishin shinkeigaku Zasshi) 2010, 112(5):439-452.
17. Ishikawa M., Mizukami K., Iwakiri M., Asada T. Immunohistochemical and immunoblot analysis of dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31(6):1177-1181.
18. Iwazaki T., Shibata I., Niwa S., Matsumoto I. Selective reduction of chromogranin A-like immunoreactivities in the prefrontal cortex of schizophrenic subjects: a postmortem study. Neurosci Lett 2004, 367(3):293-297.
19. Jacob H., Beckmann H. Prenatal development disturbances in the limbic allocortex in schizophrenics. J Neuro Transm 1986, 65(3-4):303-326.
20. Jasmin L., Rabki S.D., Granato A., Boudah A., Ohara P.T. Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex. Nature 2003, 424(6946):316-320.
21. Jasmin L., Burkey A.R., Granato A., Ohara P.T. Rostral agranular insular cortex and pain areas of the central nervous system: a tract-tracing study in the rat. J Comp Neurol 2004, 468(3):425-440.
22. Kasai K., Shenton M.E., Salisbury D.F., Onitsuka T., Toner S.K., Yurgelun-Todd D., et al. Differences and similarities in insular and temporal pole MRI gray matter volume abnormalities in first-episode schizophrenia and affective psychosis. Arch Gen Psychiatry 2003, 60(11):1069-1077.
23. Kim J.J., Youn T., Lee J.M., Kim I.Y., Kim S.I., Kwon J.S. Morphometric abnormality of the insula in schizophrenia: a comparison with obsessive-compulsive disorder and normal control using MRI. Schizophr Res 2003, 60(2-3):191-198.
24. Kloda A., Martinac B., Adams D.J. Polymodal regulation of NMDA receptor channels. Channels (Austin) 2007, 1(5):334-343.
25. Krimer L.S., Herman M.M., Saunders R.C., Boyd J.C., Hyde T.M., Carter J.M., et al. A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia. Cereb Cortex 1997, 7(8):732-739.
26. Kristiansen L.V., Patel S.A., Haroutunian V., Meador-Woodruff J.H. Expression of the NR2B-NMDA receptor subunit and its Tbr-1/CINAP regulatory proteins in postmortem brain suggest altered receptor processing in schizophrenia. Synapse 2010, 64(7):495-502.
27. Kudoh A., Ishihara H., Matsuki A. Current perception thresholds and postoperative pain in schizophrenic patients. Reg Anesth Pain Med 2000, 25(5):475-479.
28. Kunii Y, Ikemoto K, Wada A, Yang Q, Kusakabe T, Suzuki T, Niwa S. Detailed DARPP-32 expression profiles in post-mortem brains from patients with schizophrenia: an immunohistochemical study. Med Mol Morphol 2011;44 :(in press).
29. Kunii Y., Yabe H., Wada A., Yang Q., Nishiura K., Niwa S. Altered DARPP-32 expression in the superior temporal gyrus in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35(4):1139-1143.
30. Meyer-Lindenberg A., Straub R.E., Lipska B.K., Verchinski B.A., Goldberg T., Callicott J.H., et al. Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition. J Clin Invest 2007, 117:672-682.
31. Miyakawa T., Leiter L.M., Gerber D.J., Gainetdonov R.R., Sotnikova T.D., Zeng H., et al. Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. PNAS 2003, 100(15):8987-8992.
32. Murakami H., Tamasawa N., Yamashita M., Takayasu S., Nigawara T., Matsui J., et al. Altered pain perception in schizophrenia. Lancet 2010, 375(9717):864.
33. Price D.D. Psychological and neural mechanisms of the affective dimension of pain. Science 2000, 288(5472):1769-1772.
34. Quintero L., Cardenas R., Suarez-Roca H. Stress-induced hyperalgesia is associated with a reduced and delayed GABA inhibitory control that enhances post-synaptic NMDA receptor activation in the spinal cord. PAIN 2011, 152(8):1909-1922.
35. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry 1995, 52(10):805-818.
36. Souza B.R., Motta B.S., Rosa D.V., Torres K.C., Castro A.A., Comim C.M., et al. DARPP-32 and NCS-1 expression is not altered in brains of rats treated with typical or atypical antipsychotics. Neurochem Res 2008, 33(3):533-538.
37. Takahashi T., Suzuki M., Hagino H., Zhou S., Kawasaki Y., Nohara S., et al. Bilateral volume reduction of the insular cortex in patients with schizophrenia: a volumetric MRI study. Psychiatry Res 2004, 132(2):187-196.
38. Tracey I., Mantyh P.W. The cerebral signature for pain perception and its modulation. Neuron 2007, 55(3):377-391.
39. Zeng H., Chattarji S., Barbarosie M., Rondi-Reig L., Philpot B.D., Miyakawa T., et al. Forebrain-specific calcineurin knockout selectivity impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell 2001, 107(5):617-629.